Cargando…
Genetic Variants in Histone Modification Regions Predict Clinical Outcomes of Pemetrexed Chemotherapy in Lung Adenocarcinoma
OBJECTIVE: This study was conducted to investigate the association between genetic variants in histone modification regions and clinical outcomes of PEM chemotherapy in patients with lung adenocarcinoma. METHODS: Potentially functional SNPs were selected using integrated analysis of ChIP-seq and RNA...
Autores principales: | Lee, Yong Hoon, Do, Sook Kyung, Lee, Shin Yup, Kang, Hyo-Gyoung, Choi, Jin Eun, Hong, Mi Jeong, Lee, Jang Hyuck, Lee, Sunwoong, Lee, Won Kee, Jeong, Ji Yun, Shin, Kyung Min, Park, Ji Eun, Choi, Sun Ha, Seo, Hyewon, Yoo, Seung Soo, Lee, Jaehee, Cha, Seung Ick, Kim, Chang Ho, Park, Jae Yong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
S. Karger AG
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9932833/ https://www.ncbi.nlm.nih.gov/pubmed/36257285 http://dx.doi.org/10.1159/000527492 |
Ejemplares similares
-
Exonuclease 1 genetic variant is associated with clinical outcomes of pemetrexed chemotherapy in lung adenocarcinoma
por: Hong, Mi Jeong, et al.
Publicado: (2022) -
Genetic variants of NEUROD1 target genes are associated with clinical outcomes of small‐cell lung cancer patients
por: Lee, Sunwoong, et al.
Publicado: (2023) -
Promoter-Specific Variants in NeuroD1 and H3K4me3 Coincident Regions and Clinical Outcomes of Small Cell Lung Cancer
por: Yoo, Seung Soo, et al.
Publicado: (2023) -
Genetic variants in key necroptosis regulators predict prognosis of non‐small cell lung cancer after surgical resection
por: Lee, Jang Hyuck, et al.
Publicado: (2023) -
Genetic variants in LKB1/AMPK/mTOR pathway are associated with clinical outcomes of chemotherapy in non‐small cell lung cancer
por: Choi, Sun Ha, et al.
Publicado: (2022)